146 related articles for article (PubMed ID: 38744814)
1. Disentangling oncogenic amplicons in esophageal adenocarcinoma.
Ng AWT; McClurg DP; Wesley B; Zamani SA; Black E; Miremadi A; Giger O; Hoopen RT; Devonshire G; Redmond AM; Grehan N; Jammula S; Blasko A; Li X; Aparicio S; Tavaré S; ; Nowicki-Osuch K; Fitzgerald RC
Nat Commun; 2024 May; 15(1):4074. PubMed ID: 38744814
[TBL] [Abstract][Full Text] [Related]
2. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
3. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
[TBL] [Abstract][Full Text] [Related]
4. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
Murugaesu N; Wilson GA; Birkbak NJ; Watkins T; McGranahan N; Kumar S; Abbassi-Ghadi N; Salm M; Mitter R; Horswell S; Rowan A; Phillimore B; Biggs J; Begum S; Matthews N; Hochhauser D; Hanna GB; Swanton C
Cancer Discov; 2015 Aug; 5(8):821-831. PubMed ID: 26003801
[TBL] [Abstract][Full Text] [Related]
5. GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy.
Plum PS; Löser H; Zander T; Essakly A; Bruns CJ; Hillmer AM; Alakus H; Schröder W; Büttner R; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1031-1040. PubMed ID: 33300112
[TBL] [Abstract][Full Text] [Related]
6. ERα-associated translocations underlie oncogene amplifications in breast cancer.
Lee JJ; Jung YL; Cheong TC; Espejo Valle-Inclan J; Chu C; Gulhan DC; Ljungström V; Jin H; Viswanadham VV; Watson EV; Cortés-Ciriano I; Elledge SJ; Chiarle R; Pellman D; Park PJ
Nature; 2023 Jun; 618(7967):1024-1032. PubMed ID: 37198482
[TBL] [Abstract][Full Text] [Related]
7. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
8. Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
Hjortland GO; Meza-Zepeda LA; Beiske K; Ree AH; Tveito S; Hoifodt H; Bohler PJ; Hole KH; Myklebost O; Fodstad O; Smeland S; Hovig E
BMC Cancer; 2011 Oct; 11():455. PubMed ID: 22014070
[TBL] [Abstract][Full Text] [Related]
9. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Nones K; Waddell N; Wayte N; Patch AM; Bailey P; Newell F; Holmes O; Fink JL; Quinn MCJ; Tang YH; Lampe G; Quek K; Loffler KA; Manning S; Idrisoglu S; Miller D; Xu Q; Waddell N; Wilson PJ; Bruxner TJC; Christ AN; Harliwong I; Nourse C; Nourbakhsh E; Anderson M; Kazakoff S; Leonard C; Wood S; Simpson PT; Reid LE; Krause L; Hussey DJ; Watson DI; Lord RV; Nancarrow D; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Campbell PJ; Pearson JV; Grimmond SM; Barbour AP
Nat Commun; 2014 Oct; 5():5224. PubMed ID: 25351503
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas.
Ng AWT; Contino G; Killcoyne S; Devonshire G; Hsu R; Abbas S; Su J; Redmond AM; Weaver JMJ; Eldridge MD; Tavaré S; ; Edwards PAW; Fitzgerald RC
Commun Biol; 2022 Apr; 5(1):335. PubMed ID: 35396535
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
Islam F; Tang JC; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
[TBL] [Abstract][Full Text] [Related]
12. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG
Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562
[TBL] [Abstract][Full Text] [Related]
13. Chromothripsis drives the evolution of gene amplification in cancer.
Shoshani O; Brunner SF; Yaeger R; Ly P; Nechemia-Arbely Y; Kim DH; Fang R; Castillon GA; Yu M; Li JSZ; Sun Y; Ellisman MH; Ren B; Campbell PJ; Cleveland DW
Nature; 2021 Mar; 591(7848):137-141. PubMed ID: 33361815
[TBL] [Abstract][Full Text] [Related]
14. Extrachromosomal Circular DNAs, Amplified Oncogenes, and CRISPR-Cas9 System.
Pourrajab F; Zare-Khormizi MR
Mol Pharmacol; 2022 Oct; 102(4):209-215. PubMed ID: 35940609
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
[TBL] [Abstract][Full Text] [Related]
16. Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus.
Luebeck J; Ng AWT; Galipeau PC; Li X; Sanchez CA; Katz-Summercorn AC; Kim H; Jammula S; He Y; Lippman SM; Verhaak RGW; Maley CC; Alexandrov LB; Reid BJ; Fitzgerald RC; Paulson TG; Chang HY; Wu S; Bafna V; Mischel PS
Nature; 2023 Apr; 616(7958):798-805. PubMed ID: 37046089
[TBL] [Abstract][Full Text] [Related]
17. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
18. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Pongor LS; Schultz CW; Rinaldi L; Wangsa D; Redon CE; Takahashi N; Fialkoff G; Desai P; Zhang Y; Burkett S; Hermoni N; Vilk N; Gutin J; Gergely R; Zhao Y; Nichols S; Vilimas R; Sciuto L; Graham C; Caravaca JM; Turan S; Tsai-Wei S; Rajapakse VN; Kumar R; Upadhyay D; Kumar S; Kim YS; Roper N; Tran B; Hewitt SM; Kleiner DE; Aladjem MI; Friedman N; Hager GL; Pommier Y; Ried T; Thomas A
Cancer Discov; 2023 Apr; 13(4):928-949. PubMed ID: 36715552
[TBL] [Abstract][Full Text] [Related]
19. Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis.
Arai H; Ueno T; Tangoku A; Yoshino S; Abe T; Kawauchi S; Oga A; Furuya T; Oka M; Sasaki K
Cancer Genet Cytogenet; 2003 Oct; 146(1):16-21. PubMed ID: 14499691
[TBL] [Abstract][Full Text] [Related]
20. Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.
Paterson AL; Weaver JM; Eldridge MD; Tavaré S; Fitzgerald RC; Edwards PA;
BMC Genomics; 2015 Jul; 16(1):473. PubMed ID: 26159513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]